CB2 and TRPV1 receptors oppositely modulate in vitro human osteoblast activity

Francesca Rossi, Giulia Bellini, Chiara Tortora, Maria Ester Bernardo, Livio Luongo, Antonella Conforti, Nadia Starc, Iolanda Manzo, Bruno Nobili, Franco Locatelli, Sabatino Maione

Research output: Contribution to journalArticle

Abstract

Abstract In the current study, we have investigated the effect of CB2 and TRPV1 receptor ligands on in vitro osteoblasts from bone marrow of human healthy donors. A pivotal role for the endocannabinoid/endovanilloid system in bone metabolism has been highlighted. We have demonstrated a functional cross-talk between CB2 and TRPV1 in human osteoclasts, suggesting these receptors as new pharmacological target for the treatment of bone resorption disease as osteoporosis. Moreover, we have shown the presence of these receptors on human mesenchimal stem cells, hMSCs. Osteoblasts are mononucleated cells originated from hMSCs by the essential transcription factor runt-related transcription factor 2 and involved in bone formation via the synthesis and release of macrophage colony-stimulating factor, receptor activator of nuclear factor kappa-B ligand and osteoprotegerin. For the first time, we show that CB2 and TRPV1 receptors are both expressed on human osteoblasts together with enzymes synthesizing and degrading endocannabinoids/endovanilloids, and oppositely modulate human osteoblast activity in culture in a way that the CB2 receptor stimulation improves the osteogenesis whereas TRPV1 receptor stimulation inhibits it.

Original languageEnglish
Article number2853
Pages (from-to)194-201
Number of pages8
JournalPharmacological Research
Volume99
DOIs
Publication statusPublished - Jul 14 2015

Fingerprint

Cannabinoid Receptor CB2
Osteoblasts
Human Activities
Endocannabinoids
Osteogenesis
Transcription Factors
Macrophage Colony-Stimulating Factor Receptors
RANK Ligand
Osteoprotegerin
Bone Diseases
Osteoclasts
Bone Resorption
Osteoporosis
Stem Cells
Bone Marrow
Pharmacology
Ligands
Bone and Bones
In Vitro Techniques
TRPV1 receptor

Keywords

  • CB<inf>2</inf> receptor
  • Endocannabinoid/endovanilloid system
  • Human osteoblast culture
  • Osteoblast activity markers
  • TRPV<inf>1</inf> receptor

ASJC Scopus subject areas

  • Pharmacology

Cite this

Rossi, F., Bellini, G., Tortora, C., Bernardo, M. E., Luongo, L., Conforti, A., ... Maione, S. (2015). CB2 and TRPV1 receptors oppositely modulate in vitro human osteoblast activity. Pharmacological Research, 99, 194-201. [2853]. https://doi.org/10.1016/j.phrs.2015.06.010

CB2 and TRPV1 receptors oppositely modulate in vitro human osteoblast activity. / Rossi, Francesca; Bellini, Giulia; Tortora, Chiara; Bernardo, Maria Ester; Luongo, Livio; Conforti, Antonella; Starc, Nadia; Manzo, Iolanda; Nobili, Bruno; Locatelli, Franco; Maione, Sabatino.

In: Pharmacological Research, Vol. 99, 2853, 14.07.2015, p. 194-201.

Research output: Contribution to journalArticle

Rossi, F, Bellini, G, Tortora, C, Bernardo, ME, Luongo, L, Conforti, A, Starc, N, Manzo, I, Nobili, B, Locatelli, F & Maione, S 2015, 'CB2 and TRPV1 receptors oppositely modulate in vitro human osteoblast activity', Pharmacological Research, vol. 99, 2853, pp. 194-201. https://doi.org/10.1016/j.phrs.2015.06.010
Rossi, Francesca ; Bellini, Giulia ; Tortora, Chiara ; Bernardo, Maria Ester ; Luongo, Livio ; Conforti, Antonella ; Starc, Nadia ; Manzo, Iolanda ; Nobili, Bruno ; Locatelli, Franco ; Maione, Sabatino. / CB2 and TRPV1 receptors oppositely modulate in vitro human osteoblast activity. In: Pharmacological Research. 2015 ; Vol. 99. pp. 194-201.
@article{e4cc68a5c51547a89be00587caa23422,
title = "CB2 and TRPV1 receptors oppositely modulate in vitro human osteoblast activity",
abstract = "Abstract In the current study, we have investigated the effect of CB2 and TRPV1 receptor ligands on in vitro osteoblasts from bone marrow of human healthy donors. A pivotal role for the endocannabinoid/endovanilloid system in bone metabolism has been highlighted. We have demonstrated a functional cross-talk between CB2 and TRPV1 in human osteoclasts, suggesting these receptors as new pharmacological target for the treatment of bone resorption disease as osteoporosis. Moreover, we have shown the presence of these receptors on human mesenchimal stem cells, hMSCs. Osteoblasts are mononucleated cells originated from hMSCs by the essential transcription factor runt-related transcription factor 2 and involved in bone formation via the synthesis and release of macrophage colony-stimulating factor, receptor activator of nuclear factor kappa-B ligand and osteoprotegerin. For the first time, we show that CB2 and TRPV1 receptors are both expressed on human osteoblasts together with enzymes synthesizing and degrading endocannabinoids/endovanilloids, and oppositely modulate human osteoblast activity in culture in a way that the CB2 receptor stimulation improves the osteogenesis whereas TRPV1 receptor stimulation inhibits it.",
keywords = "CB<inf>2</inf> receptor, Endocannabinoid/endovanilloid system, Human osteoblast culture, Osteoblast activity markers, TRPV<inf>1</inf> receptor",
author = "Francesca Rossi and Giulia Bellini and Chiara Tortora and Bernardo, {Maria Ester} and Livio Luongo and Antonella Conforti and Nadia Starc and Iolanda Manzo and Bruno Nobili and Franco Locatelli and Sabatino Maione",
year = "2015",
month = "7",
day = "14",
doi = "10.1016/j.phrs.2015.06.010",
language = "English",
volume = "99",
pages = "194--201",
journal = "Pharmacological Research",
issn = "1043-6618",
publisher = "Academic Press",

}

TY - JOUR

T1 - CB2 and TRPV1 receptors oppositely modulate in vitro human osteoblast activity

AU - Rossi, Francesca

AU - Bellini, Giulia

AU - Tortora, Chiara

AU - Bernardo, Maria Ester

AU - Luongo, Livio

AU - Conforti, Antonella

AU - Starc, Nadia

AU - Manzo, Iolanda

AU - Nobili, Bruno

AU - Locatelli, Franco

AU - Maione, Sabatino

PY - 2015/7/14

Y1 - 2015/7/14

N2 - Abstract In the current study, we have investigated the effect of CB2 and TRPV1 receptor ligands on in vitro osteoblasts from bone marrow of human healthy donors. A pivotal role for the endocannabinoid/endovanilloid system in bone metabolism has been highlighted. We have demonstrated a functional cross-talk between CB2 and TRPV1 in human osteoclasts, suggesting these receptors as new pharmacological target for the treatment of bone resorption disease as osteoporosis. Moreover, we have shown the presence of these receptors on human mesenchimal stem cells, hMSCs. Osteoblasts are mononucleated cells originated from hMSCs by the essential transcription factor runt-related transcription factor 2 and involved in bone formation via the synthesis and release of macrophage colony-stimulating factor, receptor activator of nuclear factor kappa-B ligand and osteoprotegerin. For the first time, we show that CB2 and TRPV1 receptors are both expressed on human osteoblasts together with enzymes synthesizing and degrading endocannabinoids/endovanilloids, and oppositely modulate human osteoblast activity in culture in a way that the CB2 receptor stimulation improves the osteogenesis whereas TRPV1 receptor stimulation inhibits it.

AB - Abstract In the current study, we have investigated the effect of CB2 and TRPV1 receptor ligands on in vitro osteoblasts from bone marrow of human healthy donors. A pivotal role for the endocannabinoid/endovanilloid system in bone metabolism has been highlighted. We have demonstrated a functional cross-talk between CB2 and TRPV1 in human osteoclasts, suggesting these receptors as new pharmacological target for the treatment of bone resorption disease as osteoporosis. Moreover, we have shown the presence of these receptors on human mesenchimal stem cells, hMSCs. Osteoblasts are mononucleated cells originated from hMSCs by the essential transcription factor runt-related transcription factor 2 and involved in bone formation via the synthesis and release of macrophage colony-stimulating factor, receptor activator of nuclear factor kappa-B ligand and osteoprotegerin. For the first time, we show that CB2 and TRPV1 receptors are both expressed on human osteoblasts together with enzymes synthesizing and degrading endocannabinoids/endovanilloids, and oppositely modulate human osteoblast activity in culture in a way that the CB2 receptor stimulation improves the osteogenesis whereas TRPV1 receptor stimulation inhibits it.

KW - CB<inf>2</inf> receptor

KW - Endocannabinoid/endovanilloid system

KW - Human osteoblast culture

KW - Osteoblast activity markers

KW - TRPV<inf>1</inf> receptor

UR - http://www.scopus.com/inward/record.url?scp=84937541381&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84937541381&partnerID=8YFLogxK

U2 - 10.1016/j.phrs.2015.06.010

DO - 10.1016/j.phrs.2015.06.010

M3 - Article

C2 - 26117426

AN - SCOPUS:84937541381

VL - 99

SP - 194

EP - 201

JO - Pharmacological Research

JF - Pharmacological Research

SN - 1043-6618

M1 - 2853

ER -